VanDerLindeLPCampbellRKJacksonE. Guidelines for the intravenous administration of
drugs. Drug Intell Clin Pharm1977; 11:
30–55.
2.
RappRPButtsJDPiecoroJJJr. Guidelines for the administration of commonly used
intravenous drugs—1988 update. J Pharm Technol1988; 4:
15–32.
3.
FordDCLeistERAlgrenJTPhillipsMSSandersCL. Guidelines for the administration of intravenous medications
to pediatric patients. Washington, DC:
American Society of Hospital Pharmacists,
1982.
4.
TrisselLA. Handbook on injectable drugs. 4th
ed.Washington, DC: American Society of
Hospital Pharmacists, 1986.
5.
KingJC. Guide to parenteral admixtures. St.
Louis: Cutter Laboratories,
1987.
6.
SagerDP. Intravenous medications—a guide to preparation,
administration and nursing management.
Philadelphia: JB
Lippincott, 1980.
7.
GahartBL. Intravenous medications—a handbook for nurses and other
allied health personnel. 2nd ed.St. Louis: CV Mosby,
1977.
8.
HuffBB, ed. Physicians' desk reference. 42nd
ed.Oradel, NJ: Medical
Economics, 1988.
9.
KastrupEK, ed. Drug facts and comparisons. St.
Louis: JB Lippincott,
1989.
10.
McEvoyG, ed. American Hospital Formulary Service drug information
88. Washington, DC:
American Society of Hospital Pharmacists,
1988.
RowePC, ed. The Harriet Lane handbook: A manual for pediatric house
officers. 11th ed.Chicago: Year Book Medical
Publishers, 1987.
13.
BenitzWETatroDS, eds. The pediatric drug handbook. 2nd
ed.Chicago: Year Book Medical
Publishers, 1988.
14.
KucersABennettN McK, eds. The use of antibiotics. 3rd
ed.Philadelphia: JB
Lippincott, 1979.
15.
MeissnerHCSmithAL. The current status of
chloramphenicol. Pediatrics1979; 64:
348–56.
16.
GraybillJRCravenPC. Antifungal agents used in systemic mycoses. Activity
and therapeutic use. Drugs1983; 25:
41–62.
17.
OrlowskiJP. Cardiopulmonary resuscitation in
children. Pediatr Clin North Am1980; 27:
495–512.
18.
GreenblattDJGrossPLBologniniV. Pharmacotherapy of cardiopulmonary
arrest. Am J Hosp Pharm1976; 33:
579–83.
19.
EvansWECromWRAbromowitchMClinical pharmacodynamics of high-dose methotrexate in acute
lymphocytic leukemia. Identification of a relation between concentration and
effect. N Engl J Med1986; 314:
471–7.
20.
ArtmanMGrahamTP. Guidelines for vasodilator therapy of congestive
heart failure in infants and children. Am Heart J1987; 113:
994–1005.
21.
DelaplaneDScottJPRiggsTWSilvermanBLHuntCE. Urokinase therapy for a catheter-related right atrial
thrombus. J Pediatr1982; 100:
149–52.
22.
GilmanMETobackJWGalPErkanNV. Individualizing phenobarbital dosing in
neonates. Clin Pharm1983; 2:
258–62.
23.
FriedmanWRGeorgeBL. New concepts and drugs in the treatment of congestive
heart failure. Pediatr Clin North Am1984; 31:
1197–227.
24.
LaceyDJSingerWDHorwitzSJGilmoreH. Lorazepam therapy of status epilepticus in children
and adolescents. J Pediatr1986; 108:
771–4.
25.
VolpeJ. Neonatal seizures. N Engl J
Med1973; 289:
413–6.
26.
LentzRDBrownDMKjellstrandCM. Treatment of severe hypophosphatemia.
Ann Intern Med1978; 89:
941–4.
27.
RusconiFPariniRCavannaGAssaelBM. Monitoring of amikacin in the
neonate. Ther Drug Monit1983; 5:
179–83.
28.
ZarowitzBJMWynnRJBuckwaldSSzeflerSJ. High gentamicin trough concentrations in neonates of
less than 28 weeks gestational age. Dev Pharmacol
Ther1982; 5:
68–75.
